BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cytiva’s $1.6B Expansion Across 3 Continents to Boost Bioprocessing Supply

Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and ...

June 12, 2025 | News

Sweden’s Salipro Biotech Partners with South Korea’s Daewoong Pharmaceutical to Target Challenging Drug Discovery

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance...

June 12, 2025 | News

Samsung Bioepis Partners with NIPRO to Expand Biosimilar Access in Japan

Samsung Bioepis expands its presence in Japanese market through partnership with NIPRO Corporation Marks a step forward in widening treatments options a...

June 09, 2025 | News

CorestemChemon's Neuronata-R® Shows Promising Efficacy in Early-Stage ALS, Sets Sights on Accelerated FDA Approval

Neuronata-R®, an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral sclerosis (ALS), has demonstrated meaningfu...

May 30, 2025 | News

Huonslab Completes Patient Enrollment for Pivotal Phase 1 Trial of HLB3-002 in South Korea

Phase 1 Pivotal Study in Korea for HLB3-002 Plans to apply for marketing approval with the MFDS by the 2H 2025 -Huonslab Co., Ltd. (&ldq...

May 27, 2025 | News

Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...

May 26, 2025 | News

Celltrion’s YUFLYMA® Granted Full FDA Interchangeability with Humira® Across All Dosage Forms

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...

May 22, 2025 | News

SK Bioscience Wins Supreme Court Patent Battle Against Pfizer Over Pneumococcal Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that it the Supreme C...

May 22, 2025 | News

IDT Biologika Ramps Up Global CDMO Expansion Following SK Bioscience Acquisition

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that IDT Biologika, a...

May 21, 2025 | News

Lunit Expands U.S. Footprint with AI-Powered Breast Cancer Screening at Over 200 Sites

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imagi...

May 20, 2025 | News

Thermo Fisher Scientific Opens Cell and Gene Therapy Vision Center in South Korea

— Thermo Fisher Scientific, the world leader in serving science, has announced the official opening of its new Cell and Gene Therapy (CGT) Vision Cen...

May 15, 2025 | News

Agilent and Ubix Therapeutics Join Forces to Advance Targeted Cancer Therapies in South Korea

Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies ...

May 15, 2025 | News

Hyundai ADM Bio Withdraws IND for Penetrium™/Docetaxel and Pivots to Immunotherapy Combinations

Hyundai ADM Bio announced the voluntary withdrawal of its Investigational New Drug (IND) application for Phase 1 clinical trial evaluating Pene...

May 14, 2025 | News

Connext Completes Phase 1 for CNT201, Eyes Phase 2 Launch and Expansion into Peyronie’s Disease

Conducted under U.S. FDA-cleared IND– Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie's disease Connext, a clinical s...

May 09, 2025 | News

Stay Connected